Lopez Sanmiguel, A.; Khandwala, Y.S.; Fengshen, K.; Dawidek, M.; Tse, E.; Barbakoff, D.; Posada Calderon, L.; Carlo, M.I.; Coleman, J.; Russo, P.;
et al. Clinical and Molecular Characterization of KRAS-Mutated Renal Cell Carcinoma. Cancers 2025, 17, 3832.
https://doi.org/10.3390/cancers17233832
AMA Style
Lopez Sanmiguel A, Khandwala YS, Fengshen K, Dawidek M, Tse E, Barbakoff D, Posada Calderon L, Carlo MI, Coleman J, Russo P,
et al. Clinical and Molecular Characterization of KRAS-Mutated Renal Cell Carcinoma. Cancers. 2025; 17(23):3832.
https://doi.org/10.3390/cancers17233832
Chicago/Turabian Style
Lopez Sanmiguel, Andrea, Yash S. Khandwala, Kuo Fengshen, Mark Dawidek, Ethan Tse, Daniel Barbakoff, Lina Posada Calderon, Maria I. Carlo, Jonathan Coleman, Paul Russo,
and et al. 2025. "Clinical and Molecular Characterization of KRAS-Mutated Renal Cell Carcinoma" Cancers 17, no. 23: 3832.
https://doi.org/10.3390/cancers17233832
APA Style
Lopez Sanmiguel, A., Khandwala, Y. S., Fengshen, K., Dawidek, M., Tse, E., Barbakoff, D., Posada Calderon, L., Carlo, M. I., Coleman, J., Russo, P., Tickoo, S. K., Reuter, V. E., Reznik, E., Chen, Y.-B., & Hakimi, A. A.
(2025). Clinical and Molecular Characterization of KRAS-Mutated Renal Cell Carcinoma. Cancers, 17(23), 3832.
https://doi.org/10.3390/cancers17233832
